Medicação de alto custo para portador de sofrimento psíquico: Um estudo preliminar dos custos
Carregando...
Data
2007-01-01
Autores
Barbosa, Guilherme Correa [UNESP]
Moreno, Vânia[UNESP]
Juliani, Carmen Maria Casquel Monti [UNESP]
Spiri, Wilza Carla [UNESP]
Molina Lima, Silvana Andrea [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
The present work aims to raise the costs of high-cost drugs used to treat patients of Refractory Schizophrenia in ambulatory unit. The study was carried out in the Psychosocial Support Center, which treated 33 patients with these medications, during the period of June, 2005 to May, 2006. Data analysis disclosed that the mostly used drugs to treat the carriers of Refractory Schizophrenia were: clozapina and risperidona. It was observed that the treatment with olanzapina is more expensive than that with risperidona. The study concluded that the analysis of the consumption and costs of drugs of high cost is necessary to subside better management of the expenses and new investments in the service. Moreover, the necessity of more studies in the area was also identified to contribute with the control of costs.
Descrição
Palavras-chave
Atypical antipsychotics, Costs, Schizophrenia, clozapine, neuroleptic agent, olanzapine, quetiapine, risperidone, ziprasidone, ambulatory care, clinical article, controlled study, cost control, cost effectiveness analysis, drug cost, drug use, human, mental health service, schizophrenia
Como citar
Acta Scientiarum - Health Sciences, v. 29, n. 1, p. 19-23, 2007.